Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

NCT06425302

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 0152 Birmingham, Alabama, United States
  • Local Institution - 0055 Anchorage, Alaska, United States
  • Local Institution - 0180 Phoenix, Arizona, United States
  • Local Institution - 0190 Tucson, Arizona, United States
View all 56 locations
View Trial Details
Active, Not Recruiting

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

NCT05228158

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Eisai Trial Site 131 Komaki-shi, Aichi-ken, Japan
  • Eisai Trial Site 199 Konan-shi, Aichi-ken, Japan
  • Eisai Trial Site 21 Nagakute-shi, Aichi-ken, Japan
  • Eisai Trial Site 106 Nagoya, Aichi-ken, Japan
View all 135 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

NCT04680052

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • John Muir Health Clinical Research Center Concord, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 261 locations
View Trial Details
Active, Not Recruiting

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients

NCT02390869

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy
  • AUSL di Ravenna Ravenna, RA, Italy
  • Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo Candiolo, Torino, Italy
  • Ospedale S. Giacomo di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy
View all 28 locations
View Trial Details
Active, Not Recruiting

Personalized Risk Stratification Model of Follicular Lymphoma Patients

NCT03436602

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department Reggio Emilia, RE, Italy
  • Azienda Ospedaliera Universitaria Maggiore della Carità Novara, Italy
  • Institute of Oncology Research Bellinzona, Canton Ticino, Switzerland
  • Institute of Pathology Locarno, Canton Ticino, Switzerland
View Trial Details

Related conditions